Intellectual Property
Access to 33 issued and pending patents, including background filings and those pertaining directly to the company's proprietary scaffold technology.
Experienced Management Team
The Vascular Genesis management team has experience developing medical devices and driving them through the regulatory process.
Manufacturing Facility and Regulatory System
Full QMS system compliant with 21 CFR Part 820. Recommended for ISO 13485 certification by BSI.
The Problem
Two of the primary methods of vascular access for hemodialysis patients are the arteriovenous (AV) fistula and AV graft.
Contact Us
Want to learn more about Vascular Genesis or have a question about our approach? Use the contact form and let’s start a conversation.